R
Roivant Sciences Ltd. (ROIV)
NMS – Real Time Price. Currency in USD
26.52
-0.83 (-3.03%)
At close: Mar 27, 2026, 4:00 PM EDT
26.52
0.00 (0.00%)
After-hours: Mar 27, 2026, 4:34 PM EDT

NMS – Real Time Price. Currency in USD
26.52
-0.83 (-3.03%)
At close: Mar 27, 2026, 4:00 PM EDT
26.52
0.00 (0.00%)
After-hours: Mar 27, 2026, 4:34 PM EDT
No Data
There are no news for this stock.
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Current ratio | 30.66 | 6.05 | 10 | |
| Quick ratio | 30.66 | 5.63 | 10 | |
| Debt to Equity | 0.03 | 0.30 | 9.0 | |
| Debt to Assets | 0.02 | 1.04 | 9.0 | |
| Interest coverage | N/A | -16.91 | 1.0 | |
| Weighted average score | 7.8 | |||
| METRIC | 2021 | 2022 | 2023 | 2024 | TTM |
|---|---|---|---|---|---|
| Total Revenue | 55M | 61M | 33M | 29M | 13M |
| Gross Profit | 46M | 29M | 21M | 21M | 8M |
| Operating Income | -1.21B | -1.08B | -825M | -1.11B | -1.22B |
| Net Income | -845M | -1.01B | 4.35B | -172M | -809M |
| EBITDA | N/A | -1.05B | -814M | -1.11B | -1.21B |
| NAME | REVENUE GROWTH | EPS GROWTH | SCORE |
|---|---|---|---|
| Current quarter | -49.59 | -0.37 | 1.0 |
| Next quarter | 39.8 | -12.23 | 5.5 |
| Current year | -67.67 | -366.11 | 1.0 |
| Next year | 376.33 | -5.86 | 5.5 |
| Weighted average score | 3.3 | ||
| NAME | REVENUE | NET INCOME | EPS | FCF | SCORE |
|---|---|---|---|---|---|
| Q/Q | 27.24 | -134.22 | 16.04 | 1.01 | 5.8 |
| Y/Y | -77.82 | -256.97 | -173.7 | 8.38 | 2.3 |
| 3y average | -15.64 | 135.9 | 150.49 | -7.58 | 5.5 |
| 5y average | 4.11 | 47.17 | 150.49 | -4.01 | 6.3 |
| Weighted average score | 5.0 | ||||
| NAME | CURRENT | INDUSTRY | SCORE |
|---|---|---|---|
| Dividend yield | 0.00 | N/A | 1.0 |
| Payout ratio | 0.00 | N/A | 1.0 |
| 5-year dividend growth rate | N/A | N/A | 1.0 |
| Years of dividend increase | N/A | N/A | 1.0 |
| Weighted average score | 1.0 | ||
| NAME | SCALE | SCORE |
|---|---|---|
| Market share | Narrow | 2.0 |
| Intangible assets | Narrow | 4.0 |
| Switching costs | None | 1.0 |
| Network effect | None | 1.0 |
| Economies of scale | Narrow | 3.0 |
| Weighted average score | 2.2 | |
Company's cash reserves $1.5B significantly exceed its total debt $108.9M, ensuring strong financial flexibility
Total current assets $4.7B exceed Total current liabilities $152.0M, highlighting excellent liquidity
Debt-to-equity ratio (0.0) is well below the industry average (0.3), showcasing prudent financial management
Interest expense exists but EBIT data is unavailable, indicating potential profitability concerns
Negative free cash flow -$191.5M limits the company's ability to reinvest or pay down debt